{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:22:28Z","timestamp":1740144148586,"version":"3.37.3"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T00:00:00Z","timestamp":1680220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T00:00:00Z","timestamp":1680220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Gencor Pacific Ltd"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Non-steroidal anti-inflammatory drugs (NSAIDs) and analgesics are used frequently by athletes either prophylactically for the prevention of pain, or to accelerate recovery following an injury. However, these types of pain management strategies have been shown to inhibit signalling pathways (e.g., cyclooxygenase-2) that may hinder muscular adaptations such as hypertrophy and strength. Nutraceuticals such as palmitoylethanolamide (PEA) have analgesic properties that act via different mechanisms to NSAIDS\/analgesics. Furthermore, PEA has been shown to have a positive effect on sleep and may contribute positively to muscle hypertrophy via PKB activation. Although PEA has not been widely studied in the athletic or recreationally active population, it may provide an alternative solution for pain management if it is found not to interfere with, or enhance training adaptations. Therefore, the study aim is to investigate the effects of daily PEA supplementation (Levagen\u2009+\u2009\u00ae) with resistance training on lean body mass, strength, power and physical performance and outcomes of recovery (e.g., sleep) compared to placebo.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This double-blind, randomised controlled study will take place over an 11-week period (including 8-weeks of progressive resistance training). Participants for this study will be 18\u201335\u00a0years old, healthy active adults that are not resistance trained. Participants will attend a familiarisation (week 0), pre-testing (week 1) and final-testing (week 11). At the pre-testing and final-testing weeks, total lean body mass (dual-energy X-ray absorptiometry; DXA), total mid-thigh cross sectional area (pQCT), maximal muscular strength (1 repetition maximum bench press, isometric mid-thigh pull) and power (countermovement jump and bench throw) will be assessed. Additionally, circulating inflammatory cytokines and anabolic hormones, sleep quality and quantity (ActiGraph), pain and subjective wellbeing (questionnaires) will also be examined.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>This study\u00a0is designed to investigate the effects that PEA may have on pre-to post intervention changes in total body and regional lean muscle mass, strength, power, sleep, subjective wellbeing, and pain associated with resistance training and menstruation compared with the placebo condition. Unlike other NSAIDs and analgesics, which may inhibit muscle protein synthesis\u00a0and training adaptations, PEA\u00a0which provides analgesia via alternative mechanisms may provide an alternative pain management solution. It is therefore important to determine if this analgesic compound interferes with or enhances training adaptations so that athletes and active individuals can make an informed decision on their pain management strategies.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>Australian New Zealand Clinical Trials Registry (ANZCTR: ACTRN12621001726842p).<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13063-023-07199-y","type":"journal-article","created":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T11:09:37Z","timestamp":1680606577000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A randomised controlled trial assessing the potential of palmitoylethanolamide (PEA) to act as an adjuvant to resistance training in healthy adults: a study protocol"],"prefix":"10.1186","volume":"24","author":[{"given":"Zoya","family":"Huschtscha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jackson J.","family":"Fyfe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon A.","family":"Feros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew C.","family":"Betik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher S.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luana C.","family":"Main","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gavin","family":"Abbott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sze-Yen","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin C.","family":"Refalo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Gerhardy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Grunwald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"May","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Silver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig M.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5620-4788","authenticated-orcid":false,"given":"D. Lee","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,31]]},"reference":[{"key":"7199_CR1","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.3390\/nu13051620","volume":"13","author":"F Campa","year":"2021","unstructured":"Campa F, Toselli S, Mazzilli M, Gobbo LA, Coratella G. Assessment of body composition in athletes: A narrative review of available methods with special reference to quantitative and qualitative bioimpedance analysis. Nutrients. 2021;13:1620. https:\/\/doi.org\/10.3390\/nu13051620.","journal-title":"Nutrients"},{"key":"7199_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1371\/journal.pone.0133188","volume":"10","author":"B Jones","year":"2015","unstructured":"Jones B, Till K, Barlow M, Lees M, O\u2019Hara JP, Hind K. Anthropometric and three-compartment body composition differences between Super League and Championship rugby league players: Considerations for the 2015 season and beyond. PLoS One. 2015;10:7. https:\/\/doi.org\/10.1371\/journal.pone.0133188.","journal-title":"PLoS One"},{"issue":"17","key":"7199_CR3","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1080\/02640414.2015.1012099","volume":"33","author":"SL Moss","year":"2015","unstructured":"Moss SL, McWhannell N, Michalsik LB, Twist C. Anthropometric and physical performance characteristics of top-elite, elite and non-elite youth female team handball players. J Sports Sci. 2015;33(17):1780\u20139. https:\/\/doi.org\/10.1080\/02640414.2015.1012099.","journal-title":"J Sports Sci"},{"issue":"4","key":"7199_CR4","first-page":"387","volume":"49","author":"S Sedano","year":"2009","unstructured":"Sedano S, Vaeyens R, Philippaerts RM, Redondo JC, Cuadrado G. Anthropometric and anaerobic fitness profile of elite and non-elite female soccer players. J Sports Med Phys Fitness. 2009;49(4):387.","journal-title":"J Sports Med Phys Fitness"},{"issue":"2","key":"7199_CR5","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1123\/ijspp.2015-0048","volume":"11","author":"K Till","year":"2016","unstructured":"Till K, Jones B, O\u2019Hara J, Barlow M, Brightmore A, Lees M, Hind K. Three-compartment body composition in academy and senior rugby league players. IJSPP. 2016;11(2):191\u20136. https:\/\/doi.org\/10.1123\/ijspp.2015-0048.","journal-title":"IJSPP"},{"key":"7199_CR6","unstructured":"Boileau RA, Horswill CA. Body composition in sports: Measurement and applications for weight loss and gain. Exercise and sport science. Philadelphia: Lippincontt Williams and Wilkins. 2000:319\u20138."},{"key":"7199_CR7","doi-asserted-by":"publisher","unstructured":"Duthie GM, Pyne DB, Hopkins WG, Livingstone S, Hooper SL. Anthropometry profiles of elite rugby players: quantifying changes in lean mass. BJSM. 2006 1;40(3):202\u20137; doi: https:\/\/doi.org\/10.1136\/bjsm.2005.019695.","DOI":"10.1136\/bjsm.2005.019695"},{"issue":"5","key":"7199_CR8","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1161\/hypertension.aha.111.177071","volume":"58","author":"VA Cornelissen","year":"2011","unstructured":"Cornelissen VA, Fagard RH, Coeckelberghs E, Vanhees L. Impact of resistance training on blood pressure and other cardiovascular risk factors: a meta-analysis of randomized, controlled trials. Hypertension. 2011;58(5):950\u20138. https:\/\/doi.org\/10.1161\/hypertension.aha.111.177071.","journal-title":"Hypertension"},{"key":"7199_CR9","doi-asserted-by":"publisher","unstructured":"Huschtscha Z, Parr A, Porter J, Costa RJ. The effects of a high-protein dairy milk beverage with or without progressive resistance training on fat-free mass, skeletal muscle strength and power, and functional performance in healthy active older adults: a 12-week randomized controlled trial. Front Nutr. 2021;8; doi: https:\/\/doi.org\/10.3389\/fnut.2021.644865.","DOI":"10.3389\/fnut.2021.644865"},{"issue":"5","key":"7199_CR10","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1097\/JSM.0000000000000618","volume":"28","author":"DA Zideman","year":"2018","unstructured":"Zideman DA, Derman W, Hainline B, Moseley GL, Orchard J, Pluim BM, Siebert CH, Turner JA. Management of pain in elite athletes: identified gaps in knowledge and future research directions. CJSM. 2018;28(5):485\u20139. https:\/\/doi.org\/10.1097\/JSM.0000000000000618.","journal-title":"CJSM"},{"issue":"18","key":"7199_CR11","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1136\/bjsports-2019-101486","volume":"54","author":"RJ Findlay","year":"2020","unstructured":"Findlay RJ, Macrae EH, Whyte IY, Easton C, Forrest LJ. How the menstrual cycle and menstruation affect sporting performance: experiences and perceptions of elite female rugby players. BJSM. 2020;54(18):1108\u201313. https:\/\/doi.org\/10.1136\/bjsports-2019-101486.","journal-title":"BJSM"},{"issue":"17","key":"7199_CR12","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1136\/bjsports-2017-097890","volume":"51","author":"B Hainline","year":"2017","unstructured":"Hainline B, Turner JA, Caneiro JP, Stewart M, Moseley GL. Pain in elite athletes\u2014neurophysiological, biomechanical and psychosocial considerations: a narrative review. BJSM. 2017;51(17):1259\u201364. https:\/\/doi.org\/10.1136\/bjsports-2017-097890.","journal-title":"BJSM"},{"key":"7199_CR13","doi-asserted-by":"crossref","unstructured":"Hamlin MJ, Deuchrass RW, Olsen PD, Choukri MA, Marshall HC, Lizamore CA, Leong C, Elliot CA. The effect of sleep quality and quantity on athlete\u2019s health and perceived training quality. Front Sports Act Living. 2021;3.","DOI":"10.3389\/fspor.2021.705650"},{"issue":"2","key":"7199_CR14","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1136\/bjsm.2009.062166","volume":"45","author":"T Gorski","year":"2011","unstructured":"Gorski T, Cadore EL, Pinto SS, da Silva EM, Correa CS, Beltrami FG, Kruel LM. Use of NSAIDs in triathletes: prevalence, level of awareness and reasons for use. BJSM. 2011;45(2):85\u201390. https:\/\/doi.org\/10.1136\/bjsm.2009.062166.","journal-title":"BJSM"},{"issue":"4","key":"7199_CR15","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.rehab.2010.03.001","volume":"53","author":"JL Ziltener","year":"2010","unstructured":"Ziltener JL, Leal S, Fournier PE. Non-steroidal anti-inflammatory drugs for athletes: an update. Ann Phys Rehabil. 2010;53(4):278\u201388. https:\/\/doi.org\/10.1016\/j.rehab.2010.03.001.","journal-title":"Ann Phys Rehabil"},{"issue":"5","key":"7199_CR16","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1097\/JSM.0000000000000604","volume":"28","author":"CA Harle","year":"2018","unstructured":"Harle CA, Danielson EC, Derman W, Stuart M, Dvorak J, Smith L, Hainline B. Analgesic management of pain in elite athletes: a systematic review. Clinical J Sport Med. 2018;28(5):417\u201326. https:\/\/doi.org\/10.1097\/JSM.0000000000000604.","journal-title":"Clinical J Sport Med"},{"issue":"11","key":"7199_CR17","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1055\/s-2006-923811","volume":"27","author":"A Alaranta","year":"2006","unstructured":"Alaranta A, Alaranta H, Heli\u00f6vaara M, Airaksinen M, Helenius I. Ample use of physician-prescribed medications in Finnish elite athletes. Int J Sports Med. 2006;27(11):919\u201325. https:\/\/doi.org\/10.1055\/s-2006-923811.","journal-title":"Int J Sports Med"},{"key":"7199_CR18","doi-asserted-by":"publisher","unstructured":"Tscholl P, Junge A, Dvorak J. The use of medication and nutritional supplements during FIFA World Cups 2002 and 2006. BJSM. 2008 1;42(9):725\u201330; doi: https:\/\/doi.org\/10.1136\/bjsm.2007.045187.","DOI":"10.1136\/bjsm.2007.045187"},{"key":"7199_CR19","doi-asserted-by":"publisher","unstructured":"Lilja M, Mandi\u0107 M, Apr\u00f3 W, Melin M, Olsson K, Rosenborg S, Gustafsson T, Lundberg TR. High doses of anti\u2010inflammatory drugs compromise muscle strength and hypertrophic adaptations to resistance training in young adults. Acta Physiologica. 2018;222(2):e12948; doi: https:\/\/doi.org\/10.1111\/apha.12948.","DOI":"10.1111\/apha.12948"},{"issue":"2","key":"7199_CR20","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1152\/ajpendo.00423.2009","volume":"298","author":"NA Burd","year":"2010","unstructured":"Burd NA, Dickinson JM, LeMoine JK, Carroll CC, Sullivan BE, Haus JM, Jemiolo B, Trappe SW, Hughes GM, Sanders CE Jr, Trappe TA. Effect of a cyclooxygenase-2 inhibitor on postexercise muscle protein synthesis in humans. Am J Physiol Endocrinol. 2010;298(2):354\u201361. https:\/\/doi.org\/10.1152\/ajpendo.00423.2009.","journal-title":"Am J Physiol Endocrinol"},{"issue":"10","key":"7199_CR21","doi-asserted-by":"publisher","first-page":"5067","DOI":"10.1210\/jcem.86.10.7928","volume":"86","author":"TA Trappe","year":"2001","unstructured":"Trappe TA, Fluckey JD, White F, Lambert CP, Evans WJ. Skeletal Muscle PGF2\u03b1and PGE2 in Response to Eccentric Resistance Exercise: Influence of Ibuprofen and Acetaminophen. J Clin Endocr. 2001;86(10):5067\u201370. https:\/\/doi.org\/10.1210\/jcem.86.10.7928.","journal-title":"J Clin Endocr"},{"issue":"6","key":"7199_CR22","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1152\/ajpcell.00518.2005","volume":"290","author":"BA Bondesen","year":"2006","unstructured":"Bondesen BA, Mills ST, Pavlath GK. The COX-2 pathway regulates growth of atrophied muscle via multiple mechanisms. Am J Physiol Cel Physiol. 2006;290(6):1651\u20139. https:\/\/doi.org\/10.1152\/ajpcell.00518.2005.","journal-title":"Am J Physiol Cel Physiol"},{"issue":"4","key":"7199_CR23","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1152\/ajpendo.00230.2016","volume":"312","author":"CS Deane","year":"2017","unstructured":"Deane CS, Wilkinson DJ, Phillips BE, Smith K, Etheridge T, Atherton PJ. \u201cNutraceuticals\u201d in relation to human skeletal muscle and exercise. Am J Physiol Endocrinol. 2017;312(4):282\u201399. https:\/\/doi.org\/10.1152\/ajpendo.00230.2016.","journal-title":"Am J Physiol Endocrinol"},{"key":"7199_CR24","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/1486010","author":"A Paladini","year":"2017","unstructured":"Paladini A, Varrassi G, Bentivegna G, Carletti S, Piroli A, Coaccioli S. Palmitoylethanolamide in the treatment of failed back surgery syndrome. Pain Res Treat. 2017. https:\/\/doi.org\/10.1155\/2017\/1486010.","journal-title":"Pain Res Treat"},{"key":"7199_CR25","doi-asserted-by":"publisher","first-page":"11","DOI":"10.36076\/ppj\/2016.19.11","volume":"19","author":"VL Einaudi","year":"2016","unstructured":"Einaudi VL, Varrassi G. Palmitoylethanolamide, a special food for medical purposes, in the treatment of chronic pain: a pooled data meta-analysis. Pain Physician. 2016;19:11\u201324.","journal-title":"Pain Physician"},{"issue":"2","key":"7199_CR26","first-page":"99","volume":"26","author":"I Marini","year":"2012","unstructured":"Marini I, Lavinia Bartolucci M, Bortolotti F, Rosaria Gatto M, Alessandri BG. Palmitoylethanolamide versus a nonsteroidal anti-inflammatory drug in the treatment of temporomandibular joint inflammatory pain. J Orofac Pain. 2012;26(2):99.","journal-title":"J Orofac Pain"},{"key":"7199_CR27","doi-asserted-by":"crossref","unstructured":"Briskey D, Roche G, Rao A. The Effect of a Dispersible Palmitoylethanolamide (Levagen+) Compared to a Placebo for Reducing Joint Pain in an Adult Population\u2013A Randomised, Double-Blind Study. Int. J. Nutr. Food Sci. 2021;10(9).","DOI":"10.11648\/j.ijnfs.20211001.12"},{"issue":"3","key":"7199_CR28","doi-asserted-by":"publisher","first-page":"596","DOI":"10.3390\/nu12030596","volume":"12","author":"A Mallard","year":"2020","unstructured":"Mallard A, Briskey D, Richards A, Mills D, Rao A. The Effect of Orally Dosed Levagen+\u2122(palmitoylethanolamide) on Exercise Recovery in Healthy Males\u2014A Double-Blind, Randomized, Placebo-Controlled Study. Nutrients. 2020;12(3):596. https:\/\/doi.org\/10.3390\/nu12030596.","journal-title":"Nutrients"},{"issue":"11","key":"7199_CR29","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1111\/bph.13580","volume":"174","author":"S Petrosino","year":"2017","unstructured":"Petrosino S, Di Marzo V. The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations. Br J Pharmacol. 2017;174(11):1349\u201365. https:\/\/doi.org\/10.1111\/bph.13580.","journal-title":"Br J Pharmacol"},{"issue":"12","key":"7199_CR30","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1139\/apnm-2015-0350","volume":"40","author":"BJ Shad","year":"2015","unstructured":"Shad BJ, Smeuninx B, Atherton PJ, Breen L. The mechanistic and ergogenic effects of phosphatidic acid in skeletal muscle. Appl Physiol Nutr Metab. 2015;40(12):1233\u201341. https:\/\/doi.org\/10.1139\/apnm-2015-0350.","journal-title":"Appl Physiol Nutr Metab"},{"issue":"14","key":"7199_CR31","doi-asserted-by":"publisher","first-page":"9213","DOI":"10.1073\/pnas.142166599","volume":"99","author":"G Pallafacchina","year":"2002","unstructured":"Pallafacchina G, Calabria E, Serrano AL, Kalhovde JM, Schiaffino S. A protein kinase B-dependent and rapamycin-sensitive pathway controls skeletal muscle growth but not fiber type specification. PNAS. 2002;99(14):9213\u20138. https:\/\/doi.org\/10.1073\/pnas.142166599.","journal-title":"PNAS"},{"key":"7199_CR32","doi-asserted-by":"crossref","unstructured":"Rao A, Ebelt P, Mallard A, Briskey D. Palmitoylethanolamide for sleep disturbance. A double-blind, randomised, placebo-controlled interventional study. SSP. 202;5(1):1\u20138.","DOI":"10.1186\/s41606-021-00065-3"},{"issue":"3","key":"7199_CR33","doi-asserted-by":"publisher","first-page":"200","DOI":"10.7326\/0003-4819-158-3-201302050-00583","volume":"158","author":"AW Chan","year":"2013","unstructured":"Chan AW, Tetzlaff JM, Altman DG, Laupacis A, G\u00f8tzsche PC, Krle\u017ea-Jeri\u0107 K, Hr\u00f3bjartsson A, Mann H, Dickersin K, Berlin JA, Dor\u00e9 CJ. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158(3):200\u20137.","journal-title":"Ann Intern Med"},{"key":"7199_CR34","first-page":"3","volume":"5","author":"D Briskey","year":"2020","unstructured":"Briskey D, Mallard AR, Rao A. Increased absorption of palmitoylethanolamide using a novel dispersion technology system (LipiSperse\u00ae). J Nutraceuticals Food Sci. 2020;5:3.","journal-title":"J. Nutraceuticals Food Sci."},{"issue":"1","key":"7199_CR35","doi-asserted-by":"publisher","first-page":"1000114","DOI":"10.4172\/2167-0846.1000114","volume":"2","author":"JM Keppel Hesselink","year":"2013","unstructured":"Keppel Hesselink JM. Professor Rita Levi-Montalcini on nerve growth factor, mast cells and palmitoylethanolamide, an endogenous antiinflammatory and analgesic compound. J Pain Relief. 2013;2(1):1000114. https:\/\/doi.org\/10.4172\/2167-0846.1000114.","journal-title":"J Pain Relief"},{"issue":"2","key":"7199_CR36","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S8756-3282(00)00327-6","volume":"27","author":"J Rittweger","year":"2000","unstructured":"Rittweger J, Beller G, Ehrig J, Jung C, Koch U, Ramolla J, Schmidt F, Newitt D, Majumdar S, Schiessl H, Felsenberg D. Bone-muscle strength indices for the human lower leg. Bone. 2000;27(2):319\u201326. https:\/\/doi.org\/10.1016\/S8756-3282(00)00327-6.","journal-title":"Bone"},{"issue":"6","key":"7199_CR37","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.bone.2010.08.023","volume":"47","author":"I Arganda-Carreras","year":"2010","unstructured":"Arganda-Carreras I, Cordeli\u00e8res FP, Dougherty RP, Jackson JS, Schmid B, Hutchinson JR, Shefelbine SJ. BoneJ: free and extensible bone image analysis in ImageJ. Bone. 2010;47(6):1076\u20139. https:\/\/doi.org\/10.1016\/j.bone.2010.08.023.","journal-title":"Bone"},{"key":"7199_CR38","doi-asserted-by":"publisher","unstructured":"Kraemer WJ, Adams K, Cafarelli E, Dudley GA, Dooly C, Feigenbaum MS, Fleck SJ, Franklin B, Fry AC, Hoffman JR, Newton RU. American College of Sports Medicine position stand. Progression models in resistance training for healthy adults. Med Sci Sports Exerc. 2002;34(2):364\u201380. https:\/\/doi.org\/10.1097\/00005768-200202000-00027.","DOI":"10.1097\/00005768-200202000-00027"},{"key":"7199_CR39","doi-asserted-by":"publisher","unstructured":"Steiner M, Macdougall M, Brown E. The premenstrual symptoms screening tool (PSST) for clinicians. Archives of Women\u2019s Mental Health. 2003;(3):203\u20139; doi: https:\/\/doi.org\/10.1007\/s00737-003-0018-4.","DOI":"10.1007\/s00737-003-0018-4"},{"key":"7199_CR40","doi-asserted-by":"crossref","unstructured":"Kellmann M, K\u00f6lling S. Recovery and stress in sport: a manual for testing and assessment. Routledge; 2019. p.39.","DOI":"10.4324\/9780429423857-5"},{"issue":"2","key":"7199_CR41","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","volume":"28","author":"DJ Buysse","year":"1989","unstructured":"Buysse DJ, Reynolds CF III, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):193\u2013213. https:\/\/doi.org\/10.1016\/0165-1781(89)90047-4.","journal-title":"Psychiatry Res"},{"issue":"1","key":"7199_CR42","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1152\/japplphysiol.00154.2016","volume":"121","author":"RW Morton","year":"2016","unstructured":"Morton RW, Oikawa SY, Wavell CG, Mazara N, McGlory C, Quadrilatero J, Baechler BL, Baker SK, Phillips SM. Neither load nor systemic hormones determine resistance training-mediated hypertrophy or strength gains in resistance-trained young men. J Appl Physiol. 2016;121(1):129\u201338. https:\/\/doi.org\/10.1152\/japplphysiol.00154.2016.","journal-title":"J Appl Physiol"},{"key":"7199_CR43","unstructured":"International Committee of Medical Journal Editors. Defining the roles of authors and contributors. [Cited \u00a024 Jan 2023]. Available from:\u00a0http:\/\/www.icmje.org\/recommendations\/browse\/roles-and-responsibilities\/defining-the-role-of-authors-and-contributors.html."}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-023-07199-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-023-07199-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-023-07199-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T11:26:06Z","timestamp":1680607566000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-023-07199-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,31]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["7199"],"URL":"https:\/\/doi.org\/10.1186\/s13063-023-07199-y","relation":{},"ISSN":["1745-6215"],"issn-type":[{"type":"electronic","value":"1745-6215"}],"subject":[],"published":{"date-parts":[[2023,3,31]]},"assertion":[{"value":"23 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study design, as well as all consent forms and research tools have been approved by Deakin University Human Research Ethics Committee (DUHREC: 2021\u2013312) and registered in the Clinical Trials Registry (ANZCTR: ACTRN12621001726842p). Written consent will be obtained from all study participants after being provided a written and verbal explanation of the study objectives, this will also include the voluntary nature of their participation, their right to withdraw and the risks and benefits of the study. Protocol amendments will be numbered and first approved by DUHREC prior to updating on ANZCTR.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"N\/A.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None of the authors have shares, or stakes in GENCOR or any other competing interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"245"}}